Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
  1. 4 Grant or award Director acquired 7,375 shares (grant or award)
  2. 4 Grant or award Director acquired 6,217 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy Interim CFO bought 5,000 shares at $3.22 ($16,100)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Exercise or conversion SVP, Chief Scientific Officer acquired 40,000 shares (option exercise)
  7. 4 Grant or award Chief Medical Officer acquired 43,750 shares (grant or award)
  8. 4 Grant or award President, Chief Exec Officer acquired 85,000 shares (grant or award)
  9. 4 Grant or award SVP, Chief Scientific Officer acquired 43,750 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Gift Director gave 1,470 shares (gift)
  13. 4 Open-market sale SVP, Principal Accntng Officer sold 3,602 shares at $8.00 ($28,816)
  14. 4 Gift Director gave 4,500 shares (gift)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale SVP, Principal Accntng Officer sold 1,801 shares at $9.10 ($16,389)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale SVP, Chief Scientific Officer sold 10,000 shares at $10.20 ($102,000)
  20. 4 Open-market sale SVP, Principal Accntng Officer sold 1,801 shares at $10.00 ($18,010)

Page 6 of 28 · 550 filings